ST-elevation acute coronary syndrome research hub

The effect of early Landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention – A prospective, randomized, double- blinded, placebo controlled, phase IV pilot trial (STEMILAND-1)

This study is looking at whether a medicine called Landiolol can help people who have had a severe type of heart attack. Researchers want to see if giving this medicine early helps reduce further heart problems after emergency treatment.